2013
DOI: 10.1590/s0001-37652013005000011
|View full text |Cite
|
Sign up to set email alerts
|

Amylin induces hypoglycemia in mice

Abstract: Amylin is a 37-aminoacid pancreatic protein that exerts control over several metabolic events such as glycemia and lacticemia. Amylin has long been shown to induce increases in arterial plasma glucose. We decided to investigate whether amylin plays additional roles in the glucose metabolism. We evaluated glucose homeostasis using whole blood from the tail tip of fasting, conscious, unrestrained normal and streptozotocyn-induced diabetic mice following subcutaneous administration of mouse amylin. Subcutaneous i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 21 publications
0
5
0
1
Order By: Relevance
“…The diabetic animal model used in the current work, a single, relatively low, i.p. injection of STZ, shows a low ability to secrete insulin even at high glycemia and also a slight resistance to insulin and has been characterized as a mixed model of DM1 and DM2 . This model is different from the alloxan‐induced diabetic rats described above as the latter is exclusively a DM1 model, normally responsive to insulin.…”
Section: Discussionmentioning
confidence: 99%
“…The diabetic animal model used in the current work, a single, relatively low, i.p. injection of STZ, shows a low ability to secrete insulin even at high glycemia and also a slight resistance to insulin and has been characterized as a mixed model of DM1 and DM2 . This model is different from the alloxan‐induced diabetic rats described above as the latter is exclusively a DM1 model, normally responsive to insulin.…”
Section: Discussionmentioning
confidence: 99%
“…Considering that the Swiss mouse is a suitable animal model for studies of regulation of glycemia and liver metabolism [1619], in this study we evaluated the effect of the oral administration of hepatic glucose precursors on the glycemia and liver glucose production in mice subjected to IIH.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, GLP-1 levels have been shown to increase in procedures that enhance food consumption in rodents (Keleidari et al, 2018). Also, administration of amylin has been shown to produce a hypoglycemic state in healthy mice, suggesting that hypoglycemia may produce elevated amylin levels in rodents (Guerreiro et al, 2013). Lastly, the possibility exists that STZ-treated rats may display an altered metabolic rate of nicotine that could influence our nicotine IVSA results.…”
Section: Other Considerationsmentioning
confidence: 90%